Novartis drug Afinitor everolimus helps advanced breast cancer women
Novartis drug Afinitor? helps women with advanced breast cancer live significantly longer without their disease progressing – A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.